✦ LIBER ✦

Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a Phase II study

✍ Scribed by Balaña, Carmen; Gil, Miguel J.; Perez, Pedro; Reynes, Gaspar; Gallego, Oscar; Ribalta, Teresa; Capellades, Jaume; Gonzalez, Sofia; Verger, Eugenia

Book ID: 121572479
Publisher: Springer-Verlag
Year: 2014
Tongue: English
Weight: 277 KB
Volume: 9
Category: Article
ISSN: 1776-2596
DOI: 10.1007/s11523-014-0305-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary results of a phase II study:

Preliminary results of a phase II study: irinotecan (CPT 11) in chemotherapy naive patients with glioblastoma

✍ M. Fabbro; M. Frenay; E. Raymond; J.M. Rodier; V. Boige; R. Jourdan; M.L. Risse; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 157 KB

P-941 Phase II study of gefitinib (IRESS

P-941 Phase II study of gefitinib (IRESSA) administered as first linetreatment in patients with non-resectable, pneumonic-type adenocarcinoma (P-ADC)

✍ Cadranel, J.; Debove, P.; Quoix, E.; Soria, J.; Friard, S.; Perol, M.; Souquet, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 152 KB

A phase II study of cetuximab, capecitab

A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer

✍ V. Velenik; J. Ocvirk; I. Oblak; F. Anderluh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 355 KB

A phase II study of sunitinib in patient

A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer

✍ George Fountzilas; Anna Fragkoulidi; Anna Kalogera-Fountzila; Martha Nikolaidou; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 639 KB

718 ORAL Results of a phase II study wit

718 ORAL Results of a phase II study with sunitinib malate (SU11248) in patients (pts) with advanced neuroendocrine tumours (NETs)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Phase II study of temozolomide and cispl

Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease. A study of the Spanish Medical Neuro-Oncology Group (GENOM)

✍ Carmen Balaña; Antonio López-pousa; Alfonso Berrocal; Ricardo Yaya-tur; Ana Herr 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 158 KB